Abstract: The present inventions relates generally to a crystalline form (-)-[2-[4-[(4-Chloropheny1)-pheny1 methy1]-1-piperaziny1]ethoxy] acetic acide dihydrochloride, generically known as levocetirizine dihydrochloride, a process for it prepration and pharmaceutical compositions containing same.